Literature DB >> 3611780

Acetylcholine and norepinephrine concentrations in the heart of spontaneously hypertensive rats: a parasympathetic role in hypertension.

H Tsuboi, O Ohno, K Ogawa, T Ito, H Hashimoto, K Okumura, T Satake.   

Abstract

To determine the role of the parasympathetic system in the development of essential hypertension, the concentrations of acetylcholine (ACh) as a parasympathetic marker and norepinephrine (NE) as a sympathetic marker were measured simultaneously in the heart of spontaneously hypertensive rats (SHR) at 4, 10 and 27 weeks of age, and in age-matched control Wistar-Kyoto rats (WKY). ACh was measured using a highly sensitive and specific high performance liquid chromatography-electrochemical detection (HPLC-ECD) attached to a newly developed immobilized fixed enzyme column system. NE was measured by conventional HPLC-ECD. The ACh concentration decreased in the order right atrium (RA) greater than left atrium (LA) greater than right ventricle (RV) greater than interventricular septum (IVS) greater than left ventricle (LV) in both SHR and WKY of all age groups, and NE showed an almost identical pattern. The concentration of ACh tended to increase and that of NE to decrease with age in both strains. The concentrations of ACh in the heart were significantly different in the two strains, with the levels being consistently higher in the SHR strain regardless of age, although differences were most significant at 10 weeks. The mean concentrations of NE were higher in SHR than in WKY, but the differences between the two strains were significant only in the RV and IVS. The functional meanings of a given tissue concentration of a neurotransmitter are still controversial. However, the increase in SHR heart ACh concentration, in parallel with the development of hypertension, may reflect the augmented parasympathetic activity counteracting or compensating for the augmented sympathetic drive in the early stage of hypertension.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3611780     DOI: 10.1097/00004872-198706000-00010

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  6 in total

1.  Short-term nutritional folate deficiency in rats has a greater effect on choline and acetylcholine metabolism in the peripheral nervous system than in the brain, and this effect escalates with age.

Authors:  Natalia A Crivello; Jan K Blusztajn; James A Joseph; Barbara Shukitt-Hale; Donald E Smith
Journal:  Nutr Res       Date:  2010-10       Impact factor: 3.315

2.  Role of acetylcholine in pyridostigmine-induced myocardial injury: possible involvement of parasympathetic nervous system in the genesis of cardiomyopathy.

Authors:  T Kato; S Sugiyama; Y Hanaki; A Fukushima; N Akiyama; T Ito; T Ozawa
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

3.  1,2-diacylglycerol content in myocardium from spontaneously hypertensive rats during the development of hypertension.

Authors:  J Kondo; Y Yamada; K Okumura; H Hashimoto; T Ito; T Satake
Journal:  Basic Res Cardiol       Date:  1990 Sep-Oct       Impact factor: 17.165

4.  Enalapril reduces the enhanced 1,2-diacylglycerol content and RNA synthesis in spontaneously hypertensive rat hearts before established hypertension.

Authors:  K Okumura; J Kondo; M Yoshino; K Ishikawa; H Asano; H Hashimoto; T Ito
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

5.  Altered myocardial acetylcholine and norepinephrine concentrations in right ventricular hypertrophy and failure.

Authors:  Y Yamada; K Okumura; H Hashimoto; T Ito; T Satake
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

6.  Selective attenuation of norepinephrine release and stress-induced heart rate increase by partial adenosine A1 agonism.

Authors:  Lorenz Bott-Flügel; Alexandra Bernshausen; Heike Schneider; Peter Luppa; Katja Zimmermann; Barbara Albrecht-Küpper; Raimund Kast; Karl-Ludwig Laugwitz; Heimo Ehmke; Andreas Knorr; Melchior Seyfarth
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.